Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype

Cough

Volumn 10, Issue 1, 2014, Pages

  Scholand, Mary B ^a   Wolff, Roger ^a   Crossno, Peter F ^a,b   Sundar, Krishna ^a   Winegar, Molly ^a   Whipple, Spencer ^a   Carey, Patrick ^a   Sunchild, Nicholas ^c   Coon, Hilary ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; MUCIN 5B; PROTON PUMP INHIBITOR; STEROID;

ADULT; AGED; ARTICLE; COUGHING; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; GENE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; LEICESTER COUGH QUESTIONNAIRE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MUCIN 5B GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY;

EID: 84901418994     PISSN: None     EISSN: 17459974     Source Type: Journal    
DOI: 10.1186/1745-9974-10-3     Document Type: Article

References (22)

1. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011, 364(16):1503-1512. doi:10.1056/NEJMoa1013660[published Online First: Epub Date]|, 10.1056/NEJMoa1013660, 3379886, 21506741.
2. Ryerson CJ, Abbritti M, Ley B, Elicker BM, Jones KD, Collard HR. Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology 2011, 16(6):969-975. doi:10.1111/j.1440-1843.2011.01996.x[published Online First: Epub Date]|, 10.1111/j.1440-1843.2011.01996.x, 21615619.
3. Brown KK. Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(1 Suppl):180S-185S. doi:10.1378/chest.129.1_suppl.180S[published Online First: Epub Date]|.
4. Madison JM, Irwin RS. Chronic cough in adults with interstitial lung disease. Curr Opin Pulm Med 2005, 11(5):412-416. doi:00063198-200509000-00011, 10.1097/01.mcp.0000174249.07762.37, 16093815.
5. Hope-Gill BD, Hilldrup S, Davies C, Newton RP, Harrison NK. A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168(8):995-1002. doi:10.1164/rccm.200304-597OC[published Online First: Epub Date]|, 10.1164/rccm.200304-597OC, 12917229.
6. Lalloo UG, Lim S, DuBois R, Barnes PJ, Chung KF. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Eur Respir J 1998, 11(3):702-705.
7. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824. doi:10.1164/rccm.2009-040GL[published Online First: Epub Date]|, 10.1164/rccm.2009-040GL, 21471066.
8. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165(2):277-304. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
9. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003, 58(4):339-343. 10.1136/thorax.58.4.339, 1746649, 12668799.
10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, . ATS/ERS Task Force Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805, 16055882, ATS/ERS Task Force.
11. Chatterjee SHA. Regression Analysis by Example 2000, Hoboken, New Jersey: John Wiley & Sons.
12. Zhang Y, Noth I, Garcia JG, Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 2011, 364(16):1576-1577. doi:10.1056/NEJMc1013504[published Online First: Epub Date]|, 10.1056/NEJMc1013504, 21506748.
13. Evans CM, Kim K, Tuvim MJ, Dickey BF. Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 2009, 15(1):4-11. doi:10.1097/MCP.0b013e32831da8d3[published Online First: Epub Date]|, 10.1097/MCP.0b013e32831da8d3, 2709596, 19077699.
14. Zhen G, Park SW, Nguyenvu LT, Rodriguez MW, Barbeau R, Paquet AC, Erle DJ. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am J Respir Cell Mol Biol 2007, 36(2):244-253. doi:10.1165/rcmb.2006-0180OC[published Online First: Epub Date]|, 10.1165/rcmb.2006-0180OC, 1899314, 16980555.
15. Evans CM, Koo JS. Airway mucus: the good, the bad, the sticky. Pharmacol Ther 2009, 121(3):332-348. doi:10.1016/j.pharmthera.2008.11.001[published Online First: Epub Date]|, 10.1016/j.pharmthera.2008.11.001, 19059283.
16. Seibold MA, Smith RW, Urbanek C, Groshong SD, Cosgrove GP, Brown KK, Schwarz MI, Schwartz DA, Reynolds SD. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PloS One 2013, 8(3):e58658. doi:10.1371/journal.pone.0058658[published Online First: Epub Date]|, 10.1371/journal.pone.0058658, 3603941, 23527003.
17. Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM. Airway mucus: From production to secretion. Am J Respir Cell Mol Biol 2006, 34(5):527-536. doi:10.1165/rcmb.2005-0436SF[published Online First: Epub Date]|, 10.1165/rcmb.2005-0436SF, 2644218, 16415249.
18. Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwarz MI, Kaminski N, Schwartz DA. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 2013, 1-8. doi: 10.1001/jama.2013.5827[published Online First: Epub Date]|.
19. Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med 2012, 136(6):591-600. doi:10.5858/arpa.2011-0511-OA[published Online First: Epub Date]|, 10.5858/arpa.2011-0511-OA, 22136526.
20. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006, 27(1):136-142. doi:10.1183/09031936.06.00037005[published Online First: Epub Date]|, 10.1183/09031936.06.00037005, 16387946.
21. Lechtzin N, Hilliard ME, Horton MR. Validation of the cough quality of life questionnaire in patients with idiopathic pulmonary fibrosis. Chest 2013, doi:10.1378/chest.12-2870[published Online First: Epub Date]|.
22. Horton MR, Santopietro V, Mathew L, Horton KM, Polito AJ, Liu MC, Danoff SK, Lechtzin N. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 2012, 157(6):398-406. doi:10.7326/0003-4819-157-6-201209180-00003[published Online First: Epub Date]|, 10.7326/0003-4819-157-6-201209180-00003, 22986377.